Slade assists hospitals with clinical trials by providing compounding services from our Medsafe-licensed facility. Currently supporting over 200 clinical trials in Australia and New Zealand, our experience covers Phase 1-4 studies, primarily in oncology and haematology.
Slade’s clinical trials service includes national clinical trial co-ordination to ensure relevant criteria is met for the compounding of investigational products. Our Avondale compounding facility has dedicated trials staff who have complete oversight over the management and segregated storage of clinical trial drugs in validated and monitored equipment.
